FDA Authorizes Intradermal Jynneos Monkeypox Outbreak
Under the Jynneos EUA, intradermal administration of the vaccine has been authorized in individuals 18 years of age and older.
Stay updated with breaking news from Accessed August. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Under the Jynneos EUA, intradermal administration of the vaccine has been authorized in individuals 18 years of age and older.
Late-breaking oral presentation at WCLC features first results from TROPION-Lung02 trial of Daiichi Sankyo and AstraZeneca's TROP2 directed antibody drug conjugate Initial results from the TROPION-Lung02
The FDA has approved Nubeqa (darolutamide) plus docetaxel for the treatment of metastatic hormone-sensitive prostate cancer.
TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)--Aug 9, 2022--
The FDA has approved Enhertu (fam-trastuzumab-deruxtecan-nxki) for adults with unresectable or metastatic HER2-low breast cancer.